Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

XLV vs IYH: Which Healthcare ETF Wins on Cost and Yield?

State Street's fund charges just 0.08% annually versus 0.38% for iShares, but the broader portfolio offers 100 holdings versus 60.

XLV vs IYH: Which Healthcare ETF Wins on Cost and Yield?

Published July 27, 2026 · Category: Finance

Overview

State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides lower-cost exposure to blue-chip healthcare names, while the iShares U.S. Healthcare ETF (NYSEMKT:IYH) offers a broader portfolio with nearly twice as many holdings.

Investors looking to allocate capital to the medical sector often compare these two prominent funds. While both provide exposure to pharmaceutical and biotech giants, they differ significantly in their assets under management (AUM), cost structures, and depth of holdings, which may influence results for long-term investors.

Details

Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.